Semin Neurol 2004; 24(1): 49-62
DOI: 10.1055/s-2004-829596
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Thymectomy in the Management of Myasthenia Gravis

Alfred Jaretzki1  III , Kenneth M. Steinglass1 , Joshua R. Sonett1 , 2
  • 1Professor of Clinical Surgery, Department of Surgery, New York Presbyterian Hospital, Columbia Presbyterian Medical Center, College of Physicians & Surgeons, Columbia University, New York, New York
  • 2Associate Professor of Clinical Surgery, Department of Surgery, New York Presbyterian Hospital, Columbia Presbyterian Medical Center, College of Physicians & Surgeons, Columbia University, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
01. Juli 2004 (online)

Preview

There continues to be a debate regarding the effectiveness of thymectomy in the treatment of nonthymomatous myasthenia gravis (MG) and, when undertaken, which thymectomy technique is the procedure of choice. The debate persists primarily because of the lack of controlled prospective studies. Analysis has been complicated by the absence, until very recently, of accepted objective definitions of severity of the illness and response to therapy as well as variable patient selection, timing of surgery, type of surgery, and methods of analysis of results. Without resolution of these issues by properly controlled prospective studies, there can be no unequivocal determination of the effectiveness of thymectomy or valid comparison of the various thymectomy techniques. In this review, based on previous analyses, attempts will be made to clarify some of the controversial issues concerning thymectomy for nonthymomatous MG and make limited recommendations based on the best available evidence.

REFERENCES

Alfred Jaretzki IIIM.D. 

21 Little Point Street, P.O. Box 365, Essex

CT 06426

eMail: aj31@columbia.edu